Psoriasis is characterized by excessive growth and aberrant differentiation of keratinocytes and considered to be an immune-mediated complex multigenic disease. Experiments using skin grafts onto SCID or athymic nude mice revealed that the development of psoriasis requires the interaction of keratinocytes and immunocytes, such as T cells in particular. T-helper 17 (Th17) cells are a newly identified T cell subset because they produce IL-17, which is distinct from Th1 and Th2, and have been implicated in the pathogenesis of psoriasis. Th17 cells produce a variety of cytokines, including IL-17A, IL-17F, IL-22, IL-21, and TNF-a. IL-22 was proved to mediate acanthosis through the activation of keratinocytes Stat3
in vivo. Evidence has demonstrated that psoriatic lesions contain increased Th17 and mRNAs of aforementioned Th17 cytokines as well as IL-23, which plays a critical role in maturation and activation of Th17. Furthermore, recent studies revealed that polymorphisms in genes that encode IL-12/23p40 and IL-23R enhance susceptibility to psoriasis. These results indicated that IL-23/Th17 represents a key axis for the pathogenesis of psoriasis, as well as the therapeutic efficacy of anti-IL-12/23p40. Corneodesmosin gene (CDSN) is a psoriasis susceptibility gene 1(PSORS1), expressed exclusively in skin, and encodes a protein needed for inter-corneocytes adhesion. We established CDSN gene targeted mice, and their transplanted skin onto nude mice demonstrated psoriasiform changes including Stat3 activation. This result suggests that corneodesmosin might play a role in the epidermal differentiation program and control of Stat3. Recent findings of other psoriasis susceptibility genes, including epidermal differentiation complex (EDC), together with genes related to immunity, implicate a contribution of epitasis to the pathogenesis of psoriasis.
View full abstract